Calithera Biosciences Inc Sustainability Reports
Calithera Biosciences, Inc. was a clinical-stage bio-pharmaceutical company that focused on discovering and developing small-molecule oncology therapeutics. The enterprise primarily developed targeted drugs aimed at disrupting cellular metabolic pathways to inhibit tumor growth.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 54930042TDFRLM4C8X19
FIGI: BBG001V0G5Y6
4 reports from 2014 to 2020
